These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2126483
1. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway. Segovia J, Tillakaratne NJ, Whelan K, Tobin AJ, Gale K. Brain Res; 1990 Oct 08; 529(1-2):345-8. PubMed ID: 2126483 [Abstract] [Full Text] [Related]
2. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Soghomonian JJ, Gonzales C, Chesselet MF. Brain Res; 1992 Mar 27; 576(1):68-79. PubMed ID: 1515913 [Abstract] [Full Text] [Related]
3. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation? Samuel D, Kumar U, Nieoullon A. J Neurochem; 1988 Dec 27; 51(6):1704-10. PubMed ID: 3141584 [Abstract] [Full Text] [Related]
4. Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons. Segovia J, Castro R, Notario V, Gale K. Brain Res Mol Brain Res; 1991 Jul 27; 10(4):359-62. PubMed ID: 1656162 [Abstract] [Full Text] [Related]
6. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Kincaid AE, Albin RL, Newman SW, Penney JB, Young AB. Neuroscience; 1992 Dec 28; 51(3):705-18. PubMed ID: 1488118 [Abstract] [Full Text] [Related]
7. Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen. Lindefors N, Brené S, Persson H. Brain Res Mol Brain Res; 1990 Apr 28; 7(3):207-12. PubMed ID: 2159580 [Abstract] [Full Text] [Related]
8. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Soghomonian JJ, Chesselet MF. Synapse; 1992 Jun 28; 11(2):124-33. PubMed ID: 1626311 [Abstract] [Full Text] [Related]
9. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Chapman AG, Dürmuller N, Lees GJ, Meldrum BS. Neurosci Lett; 1989 Dec 15; 107(1-3):256-60. PubMed ID: 2515501 [Abstract] [Full Text] [Related]
10. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. Vernier P, Julien JF, Rataboul P, Fourrier O, Feuerstein C, Mallet J. J Neurochem; 1988 Nov 15; 51(5):1375-80. PubMed ID: 2459307 [Abstract] [Full Text] [Related]
11. Effect of dopaminergic denervation and transplant-derived reinnervation on a marker of striatal GABAergic function. Segovia J, Meloni R, Gale K. Brain Res; 1989 Jul 24; 493(1):185-9. PubMed ID: 2505886 [Abstract] [Full Text] [Related]
12. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Engber TM, Susel Z, Kuo S, Gerfen CR, Chase TN. Brain Res; 1991 Jun 21; 552(1):113-8. PubMed ID: 1717109 [Abstract] [Full Text] [Related]
13. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Christensson-Nylander I, Herrera-Marschitz M, Staines W, Hökfelt T, Terenius L, Ungerstedt U, Cuello C, Oertel WH, Goldstein M. Exp Brain Res; 1986 Jun 21; 64(1):169-92. PubMed ID: 2429858 [Abstract] [Full Text] [Related]
14. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Lindefors N, Brene S, Herrera-Marschitz M, Persson H. Exp Brain Res; 1989 Jun 21; 77(3):611-20. PubMed ID: 2572447 [Abstract] [Full Text] [Related]
15. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic system in monkeys. Apicella P, Trouche E, Nieoullon A, Legallet E, Dusticier N. Neuroscience; 1990 Jun 21; 38(3):655-66. PubMed ID: 2125332 [Abstract] [Full Text] [Related]
16. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Romero J, Berrendero F, Pérez-Rosado A, Manzanares J, Rojo A, Fernández-Ruiz JJ, de Yebenes JG, Ramos JA. Life Sci; 2000 Jun 21; 66(6):485-94. PubMed ID: 10794065 [Abstract] [Full Text] [Related]
17. Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Normand E, Popovici T, Onteniente B, Fellmann D, Piatier-Tonneau D, Auffray C, Bloch B. Brain Res; 1988 Jan 26; 439(1-2):39-46. PubMed ID: 3129123 [Abstract] [Full Text] [Related]
18. Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection. Nitsch C, Riesenberg R. Brain Res; 1988 Sep 27; 461(1):127-42. PubMed ID: 3224272 [Abstract] [Full Text] [Related]
19. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Pasinetti GM, Morgan DG, Finch CE. Exp Neurol; 1991 May 27; 112(2):131-9. PubMed ID: 1674692 [Abstract] [Full Text] [Related]
20. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra. Saavedra JM, Setler PE, Kebabian JW. Brain Res; 1978 Aug 04; 151(2):339-52. PubMed ID: 679013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]